Video & Transcript Research : 'overdose'

Page 2 of 47
AZ

Arizona 2026 Regular Session

03/25/2026 - Senate Regulatory Affairs and Government Efficiency

Regulatory Affairs and Government Efficiency

Summary: The committee first heard House Bill 2308, which would prohibit dental insurers and their holding companies from owning dental practices or other businesses regulated by the Arizona Board of Dental Examiners. The sponsor and Arizona Dental Association argued the bill is meant to prevent vertical integration and payer control over provider care, while Delta Dental of Arizona opposed it, saying the measure would block nonprofit insurers from investing in clinics for indigent care and create regulatory burdens. After discussion about private equity ownership in dentistry and whether nonprofit insurers should be exempted, the committee voted 7-0 to give HB 2308 a do pass recommendation. The committee then took up House Bill 4001, as amended, which creates a licensing and enforcement framework for alternative nicotine products beginning in 2028, restricts youth-targeted marketing, and increases penalties for selling to minors or manufacturing/distributing without a license. Supporters, including the sponsor, Border Security Alliance, and industry representatives, said the bill would improve supply-chain transparency, curb illegal products, and strengthen youth access enforcement. Opponents, including the American Cancer Society Cancer Action Network, argued the bill should instead create a full tobacco retail licensing system and include broader nicotine definitions, while also warning that enforcement resources would be insufficient. The committee adopted the amendment and then approved the bill 6-1. House Bill 2873, as amended, was also approved unanimously. The bill allows a person or organization that files a city or town referendum petition to withdraw it before it qualifies for the ballot, with retroactive application to withdrawals filed beginning January 1, 2026. The committee then heard House Bill 2408, which revises Arizona Board of Nursing complaint procedures, confidentiality rules, investigation timelines, expungement authority, and board oversight of nursing education programs. The sponsor said the bill responds to long-standing audit findings and aims to improve fairness and timeliness, while nursing board officials opposed provisions affecting education oversight and warned about patient safety, costs, and liability. Nurses and other supporters described delayed investigations and the need for expungement relief. The committee adopted the amendment and passed HB 2408 on a 5-2 vote. Additional bills heard included House Bill 2342, which limits HOA restrictions on backyard shade structures and related installations; it passed 7-0 after supporters described a family hardship case and committee members criticized HOA overreach. House Bill 2323, which extends Arizona’s motor vehicle lemon law protections to lessees, also passed unanimously after testimony from the sponsor, attorneys, and a consumer describing repeated repair failures on a leased vehicle. The committee also began hearing House Bill 4010, which would establish a Board of Genetic Counselors under the Arizona Board of Osteopathic Examiners and set licensure and disciplinary rules, but the transcript ends before any final action on that bill.
MN

Minnesota 2025 1st Special Session

House Children and Families Finance and Policy Committee 3/26/25

Children and Families Finance and Policy

Transcript Highlights:
  • In almost every fatal overdose, fentanyl seems to be involved.
  • In almost every fatal overdose, fentanyl seems to be involved.
  • In almost every fatal overdose, fentanyl seems to be involved.
  • 38.720> fentanyl In almost every fatal overdose, fentanyl seems to be involved.
  • :59:34.640> of<00:59:34.880> those ingesting, overdosing, any of those ingesting, overdosing
TX

Texas 89th Regular

Health and Human Services Apr 30th, 2025

Health & Human Services

Transcript Highlights:
  • severe health complications, including physical dependence, debilitating illnesses, and tragically overdose
  • severe health complications, including physical dependence, debilitating illnesses, and tragically overdose
  • or container of opioids, warning of the addictive nature and risk of respiratory depression and overdose
Summary: The committee met with a quorum and announced it would vote on pending bills at 10:30, with public testimony limited to two minutes. It first took up Senate Bill 905, a TDLR cleanup bill on licensing regulation of speech-language pathologists and audiologists. Senator Zafferini said the committee substitute would streamline advisory board consultation, remove obsolete provisional licenses, and allow any licensed physician to authorize hearing instruments for minors; the substitute was adopted and the bill left pending. The committee then heard House Bill 451, which would require universal screening for commercial sexual exploitation risk for children in DFPS conservatorship and youth under TJJD jurisdiction. The author and witnesses from Children at Risk, the Fort Bend Anti-Trafficking Collective, and Texas CASA supported the bill as a prevention tool with existing infrastructure and training; the committee adopted the substitute and left the bill pending. The committee next considered Senate Bill 466, which would clarify that families may request a fetal death certificate at any gestational age, while keeping existing filing requirements for physicians. A constituent father testified about losing his 11-week-old daughter and being told he could not obtain a certificate, which he said prevented funeral arrangements; the substitute was adopted and the bill left pending. Senate Bill 2311 followed, requiring residential treatment centers to have a written agreement with the school that will educate resident children before becoming operational. The author cited a local dispute where an RTC and school district lacked communication, and witnesses from Texas CASA and Disability Rights Texas supported clearer educational planning while suggesting the Education Code may need conforming changes; the bill was left pending. The committee then heard Senate Bill 2826, known as Alyssa’s Law, which would create a statewide education program on medical child abuse for medical students, health care professionals, and CPS caseworkers. The author and Sheriff Bill Weyburn described Alyssa’s case as involving repeated unnecessary surgeries and argued the bill would improve awareness and early identification, while several witnesses and members raised concerns about false accusations, impacts on medically fragile children, and the need for scientific, peer-reviewed training and safeguards. After extensive discussion, the chair left the bill pending. The committee also heard House Bill 136, which would add certified lactation consultants as Medicaid providers to expand breastfeeding support; witnesses from lactation and nutrition fields said the bill would improve access, maternal and infant health, and long-term savings, and the bill was left pending. Finally, the committee took up Senate Bill 2805, a surprise-billing/arbitration measure that would clarify provider identifiers and shift arbitration costs to the losing party. The author said the substitute was a legislative counsel draft with no substantive difference, and witnesses from the Texas Medical Association, Texas Society of Anesthesiologists, and U.S. Anesthesia Partners supported the bill as a modest improvement that would reduce administrative confusion and make arbitration fairer without weakening patient protections. Members discussed how arbitration costs affect settlement behavior and how to define the “winner” in close cases. The bill was heard but not voted out during this segment.
TX
Transcript Highlights:
  • severe health complications, including physical dependence, debilitating illnesses, and tragically, overdose
  • container of opioids, warning of the addictive nature and... and risk of respiratory depression and overdose
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Mental Health, Substance Use and Recovery Jun 21st, 2026 at 11:00 am

Joint Committee on Mental Health, Substance Use and Recovery

Transcript Highlights:
  • Overdose prevention centers do both.
  • overdose death.
  • Transmission, prevented skin and soft tissue infections, overdose mortality, overdose-related medical
  • This is what caused the overdose.
  • If there is no overdose prevention, there's one way to prevent overdose, one.
Keywords: 995, all
Summary: The Joint Committee on Mental Health, Substance Use, and Recovery held a public hearing on several harm reduction bills, including measures to decriminalize simple possession and paraphernalia, authorize overdose prevention centers, and expand access to naloxone for first responders. Chair Mindy Domb and Senator John Velis opened by describing harm reduction as an evidence-based public health strategy and noting Massachusetts’ recent decline in fatal overdoses. They emphasized that testimony would help shape whether and how the bills advance, and explained the hearing process, including time limits and written testimony. Testimony was sharply divided. Supporters, including Rep. Kate Donaghue, Sen. Cindy Friedman, Rep. Marjorie Decker, Rep. Manny Cruz, public health professionals, recovery advocates, and people with lived experience, argued that harm reduction saves lives, reduces stigma, and can connect people to treatment. They supported overdose prevention centers and decriminalization as tools to keep people alive long enough to enter recovery, and several speakers described personal losses to overdose or family experiences with addiction. Some supporters also framed the bills as racial justice measures, arguing that criminal penalties for possession have disproportionately harmed Black and brown communities. Opponents, including Sen. Nick Collins and several South End residents, argued that overdose prevention centers and decriminalization would worsen public drug use, crime, and neighborhood disorder, especially around Mass and Cass. They said current approaches such as Section 35, diversion, and police leverage into treatment are more effective, and they urged more treatment beds and recovery facilities instead of harm reduction sites. Committee members questioned witnesses about research, local siting, crime data, and the relationship between harm reduction and treatment, and several members said neighborhood impacts must be considered alongside overdose prevention. The committee did not take a vote during the hearing; it continued receiving testimony and announced a later break before resuming on H. 2196 and S. 1393.
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Higher Education Jun 21st, 2026 at 01:00 pm

Joint Committee on Higher Education

Transcript Highlights:
  • Youth do not need a substance use disorder to die of an overdose.
  • So, on a single overdose, what was two doses of NACAN.
  • In this case, all four overdosed.
  • preventable opioid overdose.
  • preventable opioid overdose.
Keywords: 995, all
Summary: The Joint Committee on Higher Education held its fourth public hearing, opening with remarks about the importance of protecting and expanding access to higher education amid federal disinvestment. The chairs also announced future informational hearings on the impact of federal cuts and on ASAP models. The hearing then focused on several bills, beginning with S. 951/H. 1462, An Act to Support College Students in Recovery, which would require recovery-focused housing on public campuses and expand naloxone access and overdose training. Senator Rausch, medical professionals, students, and advocates testified in support, emphasizing the prevalence of overdose risk among college students, the value of recovery housing, and the need for campus naloxone; committee members asked about implementation details and the existing state pilot program. Deb Schmill and Rep. Tarski gave especially personal testimony in favor of the bill, and the committee discussed broadening the naloxone language to opioid reversal agents. The committee also heard testimony on H. 1461, which would expand MassReconnect scholarships to practical nursing students at vocational and technical schools to help address the long-term care workforce shortage. Rep. Stanley argued that vocational schools graduate more practical nursing students than community colleges and serve many low-income students in areas without nearby community college programs. The committee then took up H. 1433, which would require public higher education institutions to accept IEPs and 504 plans as sufficient documentation for disability accommodations. Advocates from the National Center for Learning Disabilities described the high cost and burden of repeat testing, the lifelong nature of disabilities, and the need for more uniform access across campuses; committee members raised questions about documentation freshness, campus autonomy, and how to preserve the integrity of accommodations. Later, the committee heard S. 919/H. 1454 on modernizing the Community College Endowment Match Program so community colleges could receive state matching funds for current-use donations as well as endowments and capital gifts. Community college foundation leaders said the change would help fund immediate student needs such as food pantries, child care, emergency aid, and equipment. The hearing then moved to faculty-related bills: S. 933 on UMass faculty rights and tenure transparency, S. 930/H. 3948 on contingent faculty rights and career advancement, and S. 940/H. 1429 on an Adjunct Bill of Rights. Testimony from faculty and union representatives focused on low pay, lack of benefits, job insecurity, and the need for clearer pathways to full-time positions and fairer treatment for adjuncts who teach large shares of courses. No votes were taken during the hearing; the committee primarily received testimony and asked clarifying questions.
MO

Missouri 2026 Regular Session

Substance Abuse Prevention and Treatment Task Force Jun 24th, 2026 at 01:00 pm

Substance Abuse Prevention and Treatment Task Force

Transcript Highlights:
  • These do not cause overdose in the same way that we think about opioid overdose.
  • Study after study has shown us that they prevent overdose, fatal overdose, at a rate of 50 to 80%, which
  • Leukemia or overdose and suicide? Multifold the latter.
  • Leukemia or overdose and suicide? Multifold the latter.
  • Charles County overdose death rate reflects that.
Keywords: 959, house, all
MO

Missouri 2026 Regular Session

Substance Abuse Prevention and Treatment Task Force Jun 24th, 2026

Substance Abuse Prevention and Treatment Task Force

Transcript Highlights:
  • One is to reduce overdose and drug-related harms across Missouri.
  • lives to fatal overdose.
  • It ends up actually increasing overdoses and other related harms.
  • These do not cause overdose in the same way that we think about opioid overdose.
  • Charles County overdose death rate reflects that.
Summary: The task force meeting opened with new leadership announcements, including Senator Nick Schroer thanking outgoing chair Representative John Black and naming Representative Del Taylor as vice chair. After some initial technical difficulties with audio and Zoom, members reviewed the task force’s statutory charge under Missouri law: to hold hearings on substance use, explore solutions, draft or modify legislation, and produce recommendations for prevention and treatment. The chair said the goal for this year is to develop concrete legislative ideas for the next session, with hearings focused first on field experts and later on alternative therapies and the Department of Mental Health. Dr. Rachel Winograd gave the first major presentation, describing Missouri’s overdose crisis as increasingly complex and driven primarily by fentanyl, now compounded by xylazine and metatomidine. She said overdose deaths have declined for a third straight year, with preliminary 2025 data around 1,200 deaths, and attributed the decline to a smaller fentanyl supply, wider naloxone availability, and fewer young people entering use. Her main recommendations were to focus on reducing harm rather than trying to eliminate drug use, expand evidence-based medications for opioid use disorder—especially methadone and buprenorphine—improve access to naloxone, and loosen methadone regulations, including take-home doses, the federal 72-hour rule, and broader methadone units. She also emphasized that peer support, housing, transportation, and other practical supports matter, and noted that naloxone can still reverse fentanyl overdoses even when tranquilizers are present. Dr. Heidi Miller, the state medical director, followed with two recommendations: integrate substance use disorder care into whole-person health care and follow the science when considering substance-related legislation. She argued that primary care, maternal health, workforce training, EMS, public health, and methadone access should all be part of a coordinated model, and said reimbursement should support teams rather than isolated providers. She also urged stronger enforcement of parity between behavioral health/SUD and physical health coverage, and highlighted tobacco and alcohol as major, under-addressed causes of death in Missouri. Dr. Doug Burgess then reinforced the need for a coordinated continuum of care, comparing substance use treatment to the seamless system used for heart attacks, and said patients should have standardized assessment, discharge planning from day one, transition coordinators, peer recovery coaches, and better information-sharing between levels of care. Members asked questions about relapse, treatment court, EMS referral barriers, reimbursement, and whether buprenorphine can be started in the field; no votes were taken, and the meeting ended with plans to continue hearing testimony and use it to shape future policy recommendations.
MA
Transcript Highlights:
  • reversed maybe over a thousand overdoses in my lifetime, possibly more.
  • And this represents the lowest number of overdose deaths since 2015.
  • This next slide is just a reflection of the overdose response.
  • Beyond overdose reversal, wound care is another major issue.
  • Xylazine Beyond overdose reversal, wound care is another major issue.
Keywords: 995, all
Summary: The Special Commission on xylazine held its first meeting, with House Chair Mindy Domb and Senate Co-Chair John Keenan outlining the commission’s charge and a proposed work plan. The commission is tasked with studying the public health and safety impacts of xylazine in the illicit drug supply, including whether it should be scheduled as a controlled substance, how to regulate its production and distribution, and how to improve outreach and treatment for people exposed to it. Members were told the report deadline had been extended to March 30, 2026, and staff proposed a series of public hearings and working groups leading to a final report. The meeting also included attendance, packet materials, and procedural planning. The first major testimony came from BSAS Director Deirdre Calvert, who described xylazine’s appearance in Massachusetts drug supply data, the state’s public health alerts, and DPH’s partnership with Brandeis, CDC, and harm reduction organizations. She emphasized four priorities: reducing stigma and discrimination in health care, expanding self-directed wound care support and coverage for supplies, expanding access to drug checking and test strips, and supporting low-barrier services such as mobile vans and drop-in centers. Commission members asked about first responder awareness, medical education, and whether harm reduction services might face federal restrictions; Calvert said misinformation remains a problem and noted ongoing training efforts, including collaboration with public safety agencies. Several other speakers reinforced the need for low-barrier care and drug checking. Dr. Raghini Jala, an infectious disease and addiction medicine physician, said xylazine has become a common component of the unregulated opioid supply and urged support for rapid-response education teams, community-based drug checking, and better hospital and detox protocols for xylazine withdrawal and wounds. Recovery coach Alan Young testified from lived experience, describing severe wounds, fear of inadequate withdrawal treatment in emergency settings, and the value of mobile care vans that can provide methadone, buprenorphine, and wound care in the community. Dr. Sarah Wakeman echoed the need for naloxone, rescue breathing, low-threshold treatment, and non-stigmatizing health care settings, while Sarah Macon of the Boston Public Health Commission described Boston’s harm reduction and drug checking work, including on-site testing, wound care, and a decline in opioid mortality. Tracy Green of the Massachusetts Drug Supply Data Stream explained that xylazine has declined in recent samples while metatomidine is rising, said drug checking is increasingly used but still not enough, and argued for more funding, staffing, and statewide access to real-time drug checking and harm reduction services.
DE
Transcript Highlights:
  • overdose.
  • number of overdose deaths since 2019.
  • On International Overdose Awareness Day, we recommit ourselves to doing all we can to stop overdose deaths
  • We want to reduce those overdose deaths.
  • And with test strips, we reduce overdose.
Summary: The House convened with a quorum, accepted the prior day’s minutes, and read several committee reports and communications into the record. Members also observed moments of silence for two young people who had recently died, and the prayer and pledge were offered before the chamber moved into business. Consent calendar number 28, consisting of several resolutions, passed by voice vote. A large portion of the meeting was devoted to tributes and retirement remarks for Representative Jeff Holowski, who was praised by colleagues for his work on financial literacy, veterans’ issues, health care, diabetes policy, and constituent service, as well as for his military service and community involvement. Holowski thanked staff, colleagues, and his family, and said he was retiring to spend more time with his wife, children, and grandchildren. The chamber also recognized former Representative Harvey Kenton as a guest. The House then acted on several measures. Senate Bill 286, as amended by House Amendment 1, passed 40-0 and extends consumer protections and dealer equity standards to ATVs, side-by-sides, and vessels. Senate Bill 179, which updates the Delaware Sentencing Accountability Commission and its bench book/data analysis process, passed 27-14. Senate Substitute 2 for Senate Bill 23, the housing supply and affordability bill, was presented with extensive explanation and questions about local control, zoning, and implementation, but the transcript ends before a final vote on that measure. Senate Joint Resolution 18, designating August 31, 2026 as International Overdose Awareness Day and directing flags at half-staff, was also discussed in emotional remarks about overdose losses and the state’s ongoing response. The House later recessed for party caucuses.
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Mental Health, Substance Use and Recovery Jun 21st, 2026 at 01:00 pm

Joint Committee on Mental Health, Substance Use and Recovery

Transcript Highlights:
  • you specifically get into heroin and synthetic drug overdoses.
  • are individuals who have recurrent overdoses.
  • Even though overdose deaths decreased from 2022 to 2023, fentanyl overdoses increased.
  • They want overdose prevention offered in school settings.
  • Students also have to know about overdose response and naloxone, as the majority of youth and adult overdoses
Keywords: 995, all
Summary: The Joint Committee on Mental Health, Substance Use and Recovery opened its first public hearing of the 2025–26 session with remarks from the Senate and House chairs outlining the committee’s priorities. They noted recent work on addiction and recovery legislation, the ongoing youth behavioral health crisis, and that members might need to leave periodically for floor votes. The chairs explained hearing procedures, including three-minute testimony limits, written testimony deadlines, and reporting deadlines for Senate and House bills. The hearing then focused on several bills related to youth mental health, overdose prevention, and psychedelic treatment research. A major portion of the hearing centered on bills to improve youth crisis response and overdose prevention. Testimony strongly supported bills to print the 988 Suicide and Crisis Lifeline on student ID cards, with speakers from mental health organizations, crisis centers, and individuals sharing personal stories of depression, suicide attempts, and the importance of making 988 as familiar as 911. Another set of bills would require schools to stock naloxone and provide overdose prevention education. Physicians, harm reduction advocates, students, and grieving family members testified that school-based Narcan access and education could save lives, reduce stigma, and help students recognize overdoses and understand Good Samaritan protections. Senator O’Connor and Tamika Perry also testified for a bill to strengthen substance use prevention education and reduce overdose abandonment, emphasizing the need to teach students about overdose risks and the legal protections for calling 911. The committee also heard testimony on a bill to authorize a pilot program for psychedelic treatment in licensed facilities. Senator Friedman and several medical and behavioral health professionals argued the proposal was a narrow, research-based approach distinct from the broader ballot question rejected in 2024. They said the bill would allow only a small number of supervised clinics to use psychedelics for conditions such as depression, PTSD, anxiety, and substance use disorders, with data reporting and Department of Public Health oversight. Supporters described it as a cautious way to study promising treatments while avoiding unsupervised or commercialized use. Finally, the committee heard support for a bill to create a special commission and five-year strategic plan for children’s behavioral health services, with testimony that the current system is fragmented, difficult for families to navigate, and strained by workforce and funding challenges. No votes or final actions were taken during the hearing; the committee primarily received testimony and questions on the bills.
WY

Wyoming 2026 Regular Session

House Judiciary Committee, February 25, 2026

Judiciary

Transcript Highlights:
  • the effects and symptoms of overdose. the effects and symptoms of overdose.
  • <01:07:34.720> Patterson, overdose situation? Mr. Patterson, overdose situation? Mr.
  • <01:09:49.759> So overdoses per 10,000 um forratom. So overdoses per 10,000 um forratom.
  • <01:10:04.880> rates experiencing highratom overdose rates experiencing highratom overdose
  • users overdosing. I'm not really sure. users overdosing. I'm not really sure.
Bills: SF0071, SF0088, SF0056